Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors (Q77306461)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 July 1998
edit
Language Label Description Also known as
English
Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors
scientific article published on 01 July 1998

    Statements

    Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit